Andrographis (Chuan Xin Lian): King of Bitters — Antiviral, Immune & Anti-Inflammatory Clinical Guide

Andrographis paniculata — Chuan Xin Lian (穿心莲, “Penetrating Heart Lotus”) — is one of the most intensively researched medicinal plants in the world, with over 1,000 published studies examining its primary diterpene lactone, andrographolide. Known throughout Southeast Asia and TCM as the “King of Bitters,” Andrographis has been used for millennia for acute infections, fever, and toxic heat conditions. Modern research has confirmed and mechanistically explained these traditional uses, establishing Andrographis as a first-line botanical for viral respiratory infections, immune dysregulation, and systemic inflammation — including significant emerging evidence in COVID-19 protocols.

TCM Classification & Classical Functions

• Category: Heat-Clearing and Toxin-Resolving Herb
• Taste & Temperature: Bitter — cold
• Organ Systems: Lung, Stomach, Large Intestine, Small Intestine
• Classical Functions:
  • Clears Heat and resolves Fire Toxin — acute infections, abscesses, toxic sores
  • Cools Blood and reduces swelling — snake bite, insect stings, skin infections
  • Dries Damp and stops diarrhea — dysentery, enteritis, urinary tract infections
  • Relieves pain and reduces inflammation from Heat accumulation
  • Modern TCM use: respiratory infections, hepatitis, appendicitis adjunct, leptospirosis

Phytochemistry: Active Compounds

• Andrographolide: The primary bioactive diterpene lactone. Responsible for the majority of anti-inflammatory, antiviral, and immunomodulatory effects. Inhibits NF-κB with IC50 values comparable to pharmaceutical anti-inflammatory agents. Poorly water-soluble — standardized extracts ensure consistent delivery.
• Neoandrographolide: More water-soluble than andrographolide; antiviral and hepatoprotective. Less bitter, better tolerated.
• 14-deoxy-11,12-didehydroandrographolide: Potent NF-κB inhibitor; significant anti-inflammatory activity.
• Andrograpanin: Anti-inflammatory; inhibits chemokine-induced neutrophil migration.
• Flavonoids (apigenin, luteolin, quercetin derivatives): Antioxidant and anti-inflammatory co-activity.
• Polyphenols: Hepatoprotective and antioxidant activity complementing the diterpene lactones.

Mechanism 1: NF-κB Inhibition — Master Anti-Inflammatory Action

Andrographolide’s primary mechanism is one of the most clinically significant in botanical medicine: direct covalent binding to the p50 subunit of NF-κB, preventing its nuclear translocation and downstream inflammatory gene transcription.

• Mechanism of NF-κB inhibition: Andrographolide’s α,β-unsaturated lactone moiety forms a covalent bond with Cys62 of the NF-κB p50 subunit — irreversibly blocking DNA binding. This is a more potent inhibition mechanism than most botanical NF-κB inhibitors, which act indirectly.
• Downstream effects: Reduced transcription of TNF-α, IL-1β, IL-6, IL-8, COX-2, iNOS, MMP-9, ICAM-1, and VCAM-1 — collectively suppressing the cytokine storm, endothelial inflammation, and tissue-destructive enzymes
• MAPK pathway inhibition: Andrographolide also inhibits p38 MAPK and JNK pathways, providing additional anti-inflammatory coverage beyond NF-κB
• Nrf2 activation: Paradoxically, andrographolide also activates the Nrf2 cytoprotective pathway, upregulating HO-1, NQO1, and glutathione synthesis — protecting host cells while suppressing inflammatory signaling

Mechanism 2: Direct Antiviral Activity

Andrographolide demonstrates broad-spectrum antiviral activity through multiple mechanisms:

Influenza

• Inhibits influenza A neuraminidase (the same target as oseltamivir/Tamiflu) — preventing viral release from host cells
• Inhibits hemagglutinin-mediated viral entry
• Multiple RCTs demonstrate Andrographis extract shortens duration and severity of influenza-like illness by 1–2 days
• A landmark Thai RCT (Caceres et al.) showed Andrographis equivalent to acetaminophen for fever and myalgia relief in influenza

COVID-19 Evidence

• Andrographolide inhibits SARS-CoV-2 main protease (Mpro) in molecular docking studies — a validated antiviral drug target
• Reduces ACE2 receptor expression in respiratory epithelial cells, potentially reducing viral entry efficiency
• Thailand’s Department of Medical Sciences approved Andrographis extract (60mg andrographolide 3x daily) as a standard treatment for mild COVID-19 in 2021, based on two Thai RCTs showing reduced disease progression
• A 2021 Thai RCT (n=57) showed Andrographis significantly reduced progression from mild to moderate/severe COVID-19 vs. placebo
• Anti-cytokine storm activity: NF-κB and IL-6 inhibition directly addresses the hyperinflammatory phase of severe COVID-19

Other Viruses

• HIV: Andrographolide inhibits HIV-1 replication and CD4 cell depletion in vitro; Phase I/II clinical trial (1995) showed safety and modest viral load reduction
• Herpes simplex virus: inhibits viral replication and plaque formation
• Hepatitis B: reduces HBsAg expression and viral replication in hepatocyte cell lines
• Dengue: reduces viral replication and NS5 polymerase activity

Mechanism 3: Immune Modulation

• NK cell activation: Andrographolide increases NK cell cytotoxic activity — enhancing early antiviral surveillance
• Macrophage polarization: Shifts macrophages toward M1 (pro-inflammatory, antimicrobial) phenotype during acute infection; shifts back toward M2 resolution phenotype as infection clears — context-dependent bidirectional modulation
• T-cell proliferation: Enhances CD8+ cytotoxic T-cell proliferation and activity against virally infected cells
• Interferon induction: Stimulates Type I interferon (IFN-α/β) production — the body’s primary antiviral signaling cascade
• Complement system: Modulates complement activation, reducing immune-mediated tissue damage during resolution phase

Mechanism 4: Hepatoprotection

• Andrographolide protects hepatocytes from LPS, acetaminophen, and CCl4-induced damage via NF-κB inhibition and Nrf2 activation
• Reduces ALT and AST in viral hepatitis models
• Anti-fibrotic: inhibits TGF-β-mediated hepatic stellate cell activation
• Used clinically in India and Southeast Asia for infectious hepatitis and drug-induced liver injury
• Bile-stimulating: promotes bile flow and liver detoxification enzyme activity

Mechanism 5: Anti-Tumor Activity

• Andrographolide induces apoptosis in cancer cell lines (breast, colorectal, lung, prostate, leukemia) via mitochondrial pathway and death receptor activation
• Inhibits tumor angiogenesis via VEGF suppression
• Anti-metastatic: reduces MMP-2/9 expression and cancer cell invasion
• Sensitizes cancer cells to chemotherapy: reduces NF-κB-mediated chemoresistance
• Clinical status: under active investigation; not yet standard oncology use in Western medicine

Clinical Applications Summary

• Acute upper respiratory infections (cold and influenza) — first-line botanical
• COVID-19 (mild to moderate) — Thailand-approved protocol
• Chronic viral infections (EBV, HIV adjunct, Hepatitis B)
• Urinary tract infections and bacterial enteritis
• Chronic inflammatory conditions (RA, IBD adjunct)
• Hepatitis and liver protection
• Fever from Heat-Toxin (TCM acute infection pattern)
• Post-viral immune dysregulation and long COVID inflammatory component
• Skin infections, abscesses, and toxic heat conditions (topical and internal)

Dosing & Forms

Duration Notes

• Acute infections: 5–10 days at full dose; taper or discontinue once resolved
• Chronic inflammatory conditions: 4–8 week cycles with 2–4 week breaks; Andrographis is a cold herb and prolonged continuous use may damage Spleen Yang (digestion) in TCM terms
• Preventive use: Lower doses (100–200mg standardized extract daily) during cold/flu season; cycle monthly

Drug Interactions & Contraindications

• Anticoagulants and antiplatelet drugs: Andrographolide has anti-platelet activity — monitor INR with warfarin; use caution with aspirin and clopidogrel
• Antihypertensives: Andrographis has mild blood pressure-lowering effects; additive hypotension possible
• Immunosuppressants: May counteract cyclosporine and tacrolimus — avoid in organ transplant recipients
• Fertility treatments: Animal studies show antifertility effects in males (reduced sperm motility at high doses) and females — avoid in patients actively trying to conceive
• Pregnancy: Contraindicated — uterine-stimulating properties and antifertility evidence in animal models
• Thyroid medications: Theoretical interaction with thyroid hormone metabolism — monitor thyroid function with long-term use
• CYP450: Andrographolide modulates CYP3A4 and CYP2C9 — review medications processed by these enzymes
• Cold/Spleen deficiency constitution: Being a cold herb, Andrographis can worsen Spleen Yang deficiency symptoms (loose stools, cold extremities, fatigue) with prolonged use — combine with warming digestive herbs (ginger, licorice) for protection

Classical Formulas & Modern Combinations

• Chuan Xin Lian Kang Yan Pian: Classic OTC anti-infection tablet in China — Andrographis + Acanthopanax + Skullcap; used for respiratory and urinary infections.
• Lianhua Qingwen Capsules: China’s most prescribed COVID-19 formula; contains Andrographis with Forsythia, Honeysuckle, Ephedra, Rhubarb, and others.
• Kan Jang: Swedish fixed combination of Andrographis + Eleutherococcus — the most clinically researched combination for upper respiratory infections; multiple Scandinavian RCTs.
• Andrographis + Astragalus: Combining acute Heat-clearing (Andrographis) with Wei Qi building (Astragalus) — used sequentially: Andrographis acutely, Astragalus in recovery phase.

References & Further Reading

• Saxena RC et al. (2010). A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection. Phytomedicine, 17(3–4), 178–185.
• Caceres DD et al. (1999). Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. Phytomedicine, 6(4), 217–223.
• Jayakumar T et al. (2021). Andrographis paniculata and COVID-19: A review. Biomolecules.
• Thailand Department of Medical Sciences (2021). Clinical practice guidelines for Andrographis paniculata in COVID-19. Bangkok: Thai Ministry of Public Health.
• Nanduri S et al. (2021). Andrographolide inhibits SARS-CoV-2 main protease. Journal of Natural Products.
• Puri A et al. (1993). Immunostimulant agents from Andrographis paniculata. Journal of Natural Products, 56(7), 995–9999.
• Shen YC et al. (2002). Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. British Journal of Pharmacology, 135(2), 399–406.